Thymmune Therapeutics, Inc

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven platform to engineer induced pluripotent stem cell (iPSC)-derived thymic cells for restoring immune function in aging and disease. The company is developing therapies to treat immunodeficiencies, transplant-related complications, and autoimmune disorders through scalable off-the-shelf cell manufacturing.